Russell Investments Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
75,070
+1,220
+2% +$41K ﹤0.01% 1879
2025
Q4
$3.16M Sell
73,850
-44,135
-37% -$1.66M ﹤0.01% 1602
2025
Q3
$3.34M Buy
117,985
+101,528
+617% +$3.04M ﹤0.01% 1564
2025
Q2
$308K Buy
16,457
+6,746
+69% +$128K ﹤0.01% 2512
2025
Q1
$175K Buy
9,711
+512
+6% +$10.4K ﹤0.01% 2629
2024
Q4
$155K Sell
9,199
-1,349
-13% -$25.9K ﹤0.01% 2597
2024
Q3
$171K Buy
10,548
+124
+1% +$1.46K ﹤0.01% 2549
2024
Q2
$85.7K Sell
10,424
-1,322
-11% -$13.8K ﹤0.01% 2662
2024
Q1
$174K Sell
11,746
-2,810
-19% -$37.9K ﹤0.01% 2476
2023
Q4
$211K Sell
14,556
-4,772
-25% -$48.8K ﹤0.01% 2422
2023
Q3
$209K Sell
19,328
-1,790
-8% -$21.5K ﹤0.01% 2479
2023
Q2
$272K Sell
21,118
-40
-0.2% -$541 ﹤0.01% 2407
2023
Q1
$279K Buy
21,158
+5,589
+36% +$88.8K ﹤0.01% 2410
2022
Q4
$234K Buy
15,569
+622
+4% +$5.7K ﹤0.01% 2532
2022
Q3
$175K Buy
14,947
+14,070
+1,604% +$190K ﹤0.01% 2574
2022
Q2
$9K Sell
877
-8,245
-90% -$166K ﹤0.01% 2848
2022
Q1
$272K Buy
9,122
+1,165
+15% +$31.5K ﹤0.01% 2394
2021
Q4
$210K Sell
7,957
-488
-6% -$14.7K ﹤0.01% 2706
2021
Q3
$305K Hold
8,445
﹤0.01% 2645
2021
Q2
$365K Sell
8,445
-17,305
-67% -$653K ﹤0.01% 2711
2021
Q1
$879K Sell
25,750
-34,245
-57% -$1.36M ﹤0.01% 2302
2020
Q4
$2.1M Sell
59,995
-33,060
-36% -$957K ﹤0.01% 1733
2020
Q3
$2.23M Buy
93,055
+30,200
+48% +$742K ﹤0.01% 1612
2020
Q2
$1.15M Buy
62,855
+16,579
+36% +$298K ﹤0.01% 1976
2020
Q1
$719K Buy
46,276
+42,536
+1,137% +$905K ﹤0.01% 2005
2019
Q4
$79K Sell
3,740
-6,290
-63% -$130K ﹤0.01% 2934
2019
Q3
$188K Sell
10,030
-3,746
-27% -$77.4K ﹤0.01% 2630
2019
Q2
$359K Buy
13,776
+10,686
+346% +$241K ﹤0.01% 2371
2019
Q1
$80K Buy
+3,090
New +$70.6K ﹤0.01% 2755
2017
Q1
Sell
-19,075
Closed -$459K 3058
2016
Q4
$459K Buy
+19,075
New +$546K ﹤0.01% 2496

Other funds holding RIGL